BCL2 and breast cancer: It was shown that the differentiation of breast cancer stem cells occurred by the knockdown of CD44 and caused the loss of the CSC phenotype along with the reduced expression of Bcl-2 and Muc-1 proteins, reducing metastasis and tumorigenesis [111].